Restricted vs independent adviser status: how the label affects IFA PII

~5 min read

Reviewed by Matthew Bartlett, Director · Last reviewed 2026-07-06

The label an IFA firm applies to itself under the FCA regime — "independent" or "restricted" — is more than a marketing choice. It has specific regulatory meaning under COBS 6.2A, and it materially affects the PII exposure of the firm. Independent advisers must consider a "sufficiently wide range" of investment products; restricted advisers can limit themselves to a defined product panel or a defined product provider. The choice affects the suitability analysis the firm must perform, the disclosures it must make, and the PI claim exposure it faces at the point of recommendation. This entry sets out the distinction, its practical consequences, and how brokers underwrite the two segments differently.

The regulatory definition

COBS 6.2A defines independent advice by reference to two tests. First, the advice must be based on a comprehensive and fair analysis of the relevant market. Second, the advice must be unbiased and unrestricted — not limited by any contractual or commercial arrangement with a product provider. A firm that meets both tests can market itself as "independent". A firm that does not — because it uses a defined product panel, is tied to specific product providers, or has commercial arrangements that limit its recommendations — must describe itself as "restricted".

The distinction is disclosure-driven. Restricted firms must disclose the nature of their restriction to clients before advice is given (COBS 6.2A.6R), so clients understand what the adviser can and cannot recommend. Failure to disclose the restriction accurately is itself a rule breach and a source of claim exposure.

Independent PI exposure

An independent firm faces a broad suitability question at each recommendation — was the recommendation the most suitable available across the relevant market? A claim can argue that a different product from a different provider would have delivered better outcomes. The defence is the firm's documented product-selection process — the criteria the firm applies, the analysis of the relevant market, and the reason for the specific product recommended.

Independent firms typically face higher PII premiums than restricted firms, reflecting the broader potential claim ground. The premium delta is often 15-30% at the same firm size and turnover, though the range varies by insurer and book profile.

Restricted PI exposure

A restricted firm faces a narrower suitability question — was the recommendation suitable from within the restricted panel or provider? A claim can argue that the panel itself was insufficient for the client's needs, but not that a different provider outside the panel would have been better (assuming the restriction was disclosed clearly at the outset).

Restricted firms typically face lower PII premiums than independent firms, reflecting the narrower claim ground. The saving is meaningful for large panels but disappears where the restriction is unclear or where the panel scope shifts over time.

The disclosure risk

The single biggest claim risk on the restricted side is the disclosure. If the firm holds itself out as offering "advice" or "financial advice" without clearly explaining the restricted nature, clients can argue they thought they were receiving independent advice. FOS routinely finds against firms whose marketing materials, website copy, or client-facing documentation blur the independent/restricted line. Every restricted firm's PII proposal form now asks specifically about disclosure practice — website copy, terms of business, suitability report language.

The "hidden restriction" problem

A firm can be effectively restricted without a formal restriction. If a firm's recommended-product list has narrowed over time to a small number of providers, if the firm has commercial arrangements (introducer fees, panel membership) with those providers, or if the firm's due diligence process is not comparing genuinely against the wider market, the firm may be operating restricted without holding itself out as such. This is a live regulatory risk — the FCA has taken action against firms that describe themselves as independent but operate a de facto restricted model. From a PII perspective, insurers ask about the actual product-selection process, not just the label.

The DFM interaction

A firm that recommends a DFM (discretionary fund manager) to clients faces a specific question: is the DFM recommendation "independent" if the firm only considers a subset of DFMs? The FCA position is that a firm can be independent and still use a panel of DFMs, provided the panel selection reflects a genuine market analysis. Firms should document the DFM selection process and the criteria applied, and should refresh the analysis periodically.

The vertically integrated model

Some IFA firms are part of a vertically integrated group that owns product providers, platforms, or DFMs. Where the firm advises on group products, the firm cannot describe itself as independent — the group ownership is itself a restriction. Vertically integrated firms typically operate on a restricted basis and must disclose the group relationship clearly. PII underwriting of vertically integrated firms scrutinises the group product allocation and the client-communication of the group relationship.

Practical points at renewal

Three practical points at renewal. First, the firm's public label must match its actual practice. Second, if the firm has moved between labels — from independent to restricted or vice versa — the transition period is a claim-risk window that insurers ask about. Third, the firm's marketing materials, website, and terms of business should be reviewed periodically to ensure they reflect the current status accurately.

Worked example

Illustrative only. A four-adviser IFA firm has held itself out as "independent" since inception. At the July 2024 Consumer Duty deadline, the firm reviewed its actual practice and found that 78% of new recommendations over the previous two years had been from a panel of six providers. The remaining 22% had been from providers used only where the panel could not deliver a suitable outcome. The firm concluded that this was consistent with independent status (a documented panel used as a starting point, not a fixed restriction) but should be formalised. The firm updated its terms of business to explain the panel-plus-market-analysis process, updated its website copy, and adjusted its suitability report template to explain why the recommended product was chosen from the panel or from outside it. Post-Duty proposal-form response to insurers documented the exercise. The firm's PII placement remained on independent terms.